 | • レポートコード：MRC2102QY10030 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、136ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界の爪真菌症（爪白癬）治療薬市場について種類別（経口薬、外用薬）、用途別（18歳以下、18〜50歳、50歳以上）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・爪真菌症（爪白癬）治療薬市場の概要 ・世界の主要地域別爪真菌症（爪白癬）治療薬市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の爪真菌症（爪白癬）治療薬市場規模2015-2026：種類別（経口薬、外用薬） ・世界の爪真菌症（爪白癬）治療薬市場規模2015-2026：用途別（18歳以下、18〜50歳、50歳以上） ・爪真菌症（爪白癬）治療薬の米国市場規模2015-2020 ・爪真菌症（爪白癬）治療薬のヨーロッパ市場規模2015-2020 ・爪真菌症（爪白癬）治療薬の中国市場規模2015-2020 ・爪真菌症（爪白癬）治療薬の日本市場規模2015-2020 ・爪真菌症（爪白癬）治療薬の東南アジア市場規模2015-2020 ・爪真菌症（爪白癬）治療薬のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・爪真菌症（爪白癬）治療薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・爪真菌症（爪白癬）治療薬の市場動向・機会・課題 ・調査の結論 |
Onychomycosis is a fungal infection of the toenails or fingernails that may involve any component of the nail unit, including the matrix, bed, or plate.
Onychomycosis (Tinea Unguium) Drug is the drug for the treatment of the disease.
USA is the largest consumption place, with a consumption market share nearly 33.14% in 2016. Following USA, Europe is the second largest consumption place with the consumption market share of 23.66%.Market competition is intense. Johnson & Johnson, GSK, Novartis, Pfizer, Valeant PharmaKaken Pharmaceutical are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
Market Analysis and Insights: Global Onychomycosis (Tinea Unguium) Drug Market
The global Onychomycosis (Tinea Unguium) Drug market size is projected to reach US$ 3669.4 million by 2026, from US$ 3055.2 million in 2020, at a CAGR of 3.1% during 2021-2026.
Global Onychomycosis (Tinea Unguium) Drug Scope and Market Size
The global Onychomycosis (Tinea Unguium) Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Onychomycosis (Tinea Unguium) Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Onychomycosis (Tinea Unguium) Drug market is segmented into
Oral Medication
External Medicine
Segment by Application, the Onychomycosis (Tinea Unguium) Drug market is segmented into
Age under 18
Age 18-50
Age above 50
The Onychomycosis (Tinea Unguium) Drug market is analysed and market size information is provided by regions (countries). Segment by Application, the Onychomycosis (Tinea Unguium) Drug market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Onychomycosis (Tinea Unguium) Drug Market Share Analysis
Onychomycosis (Tinea Unguium) Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Onychomycosis (Tinea Unguium) Drug business, the date to enter into the Onychomycosis (Tinea Unguium) Drug market, Onychomycosis (Tinea Unguium) Drug product introduction, recent developments, etc.
The major vendors covered:
Johnson and Johnson
GSK
Novartis
Pfizer
Valeant Pharma
Kaken Pharmaceutical
Galderma
Xiuzheng Pharmaceutical
Letai
Qilu Pharmaceutical
1 Onychomycosis (Tinea Unguium) Drug Market Overview
1.1 Onychomycosis (Tinea Unguium) Drug Product Scope
1.2 Onychomycosis (Tinea Unguium) Drug Segment by Type
1.2.1 Global Onychomycosis (Tinea Unguium) Drug Sales by Type (2020-2026)
1.2.2 Oral Medication
1.2.3 External Medicine
1.3 Onychomycosis (Tinea Unguium) Drug Segment by Application
1.3.1 Global Onychomycosis (Tinea Unguium) Drug Sales Comparison by Application (2020-2026)
1.3.2 Age under 18
1.3.3 Age 18-50
1.3.4 Age above 50
1.4 Onychomycosis (Tinea Unguium) Drug Market Estimates and Forecasts (2015-2026)
1.4.1 Global Onychomycosis (Tinea Unguium) Drug Sales Growth Rate (2015-2026)
1.4.2 Global Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2015-2026)
1.4.3 Global Onychomycosis (Tinea Unguium) Drug Price Trends (2015-2026)
2 Onychomycosis (Tinea Unguium) Drug Estimate and Forecast by Region
2.1 Global Onychomycosis (Tinea Unguium) Drug Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Onychomycosis (Tinea Unguium) Drug Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Region (2015-2020)
2.2.2 Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Region (2015-2020)
2.3 Global Onychomycosis (Tinea Unguium) Drug Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Onychomycosis (Tinea Unguium) Drug Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Onychomycosis (Tinea Unguium) Drug Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Onychomycosis (Tinea Unguium) Drug Estimates and Projections (2015-2026)
2.4.2 Europe Onychomycosis (Tinea Unguium) Drug Estimates and Projections (2015-2026)
2.4.3 China Onychomycosis (Tinea Unguium) Drug Estimates and Projections (2015-2026)
2.4.4 Japan Onychomycosis (Tinea Unguium) Drug Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Onychomycosis (Tinea Unguium) Drug Estimates and Projections (2015-2026)
2.4.6 India Onychomycosis (Tinea Unguium) Drug Estimates and Projections (2015-2026)
3 Global Onychomycosis (Tinea Unguium) Drug Competition Landscape by Players
3.1 Global Top Onychomycosis (Tinea Unguium) Drug Players by Sales (2015-2020)
3.2 Global Top Onychomycosis (Tinea Unguium) Drug Players by Revenue (2015-2020)
3.3 Global Onychomycosis (Tinea Unguium) Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Onychomycosis (Tinea Unguium) Drug as of 2019)
3.4 Global Onychomycosis (Tinea Unguium) Drug Average Price by Company (2015-2020)
3.5 Manufacturers Onychomycosis (Tinea Unguium) Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Onychomycosis (Tinea Unguium) Drug Players (Opinion Leaders)
4 Global Onychomycosis (Tinea Unguium) Drug Market Size by Type
4.1 Global Onychomycosis (Tinea Unguium) Drug Historic Market Review by Type (2015-2020)
4.1.1 Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type (2015-2020)
4.1.2 Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Type (2015-2020)
4.1.3 Global Onychomycosis (Tinea Unguium) Drug Price by Type (2015-2020)
4.2 Global Onychomycosis (Tinea Unguium) Drug Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Onychomycosis (Tinea Unguium) Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Onychomycosis (Tinea Unguium) Drug Revenue Forecast by Type (2021-2026)
4.2.3 Global Onychomycosis (Tinea Unguium) Drug Price Forecast by Type (2021-2026)
5 Global Onychomycosis (Tinea Unguium) Drug Market Size by Application
5.1 Global Onychomycosis (Tinea Unguium) Drug Historic Market Review by Application (2015-2020)
5.1.1 Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application (2015-2020)
5.1.2 Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Application (2015-2020)
5.1.3 Global Onychomycosis (Tinea Unguium) Drug Price by Application (2015-2020)
5.2 Global Onychomycosis (Tinea Unguium) Drug Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Onychomycosis (Tinea Unguium) Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Onychomycosis (Tinea Unguium) Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Onychomycosis (Tinea Unguium) Drug Price Forecast by Application (2021-2026)
6 United States Onychomycosis (Tinea Unguium) Drug Market Facts & Figures
6.1 United States Onychomycosis (Tinea Unguium) Drug Sales Market Share by Company (2015-2020)
6.2 United States Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type (2015-2020)
6.3 United States Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application (2015-2020)
7 Europe Onychomycosis (Tinea Unguium) Drug Market Facts & Figures
7.1 Europe Onychomycosis (Tinea Unguium) Drug Sales Market Share by Company (2015-2020)
7.2 Europe Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type (2015-2020)
7.3 Europe Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application (2015-2020)
8 China Onychomycosis (Tinea Unguium) Drug Market Facts & Figures
8.1 China Onychomycosis (Tinea Unguium) Drug Sales Market Share by Company (2015-2020)
8.2 China Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type (2015-2020)
8.3 China Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application (2015-2020)
9 Japan Onychomycosis (Tinea Unguium) Drug Market Facts & Figures
9.1 Japan Onychomycosis (Tinea Unguium) Drug Sales Market Share by Company (3015-3030)
9.2 Japan Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type (2015-2020)
9.3 Japan Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application (2015-2020)
10 Southeast Asia Onychomycosis (Tinea Unguium) Drug Market Facts & Figures
10.1 Southeast Asia Onychomycosis (Tinea Unguium) Drug Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application (2015-2020)
11 India Onychomycosis (Tinea Unguium) Drug Market Facts & Figures
11.1 India Onychomycosis (Tinea Unguium) Drug Sales Market Share by Company (2015-2020)
11.2 India Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type (2015-2020)
11.3 India Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Onychomycosis (Tinea Unguium) Drug Business
12.1 Johnson and Johnson
12.1.1 Johnson and Johnson Corporation Information
12.1.2 Johnson and Johnson Business Overview
12.1.3 Johnson and Johnson Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Johnson and Johnson Onychomycosis (Tinea Unguium) Drug Products Offered
12.1.5 Johnson and Johnson Recent Development
12.2 GSK
12.2.1 GSK Corporation Information
12.2.2 GSK Business Overview
12.2.3 GSK Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Gross Margin (2015-2020)
12.2.4 GSK Onychomycosis (Tinea Unguium) Drug Products Offered
12.2.5 GSK Recent Development
12.3 Novartis
12.3.1 Novartis Corporation Information
12.3.2 Novartis Business Overview
12.3.3 Novartis Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Novartis Onychomycosis (Tinea Unguium) Drug Products Offered
12.3.5 Novartis Recent Development
12.4 Pfizer
12.4.1 Pfizer Corporation Information
12.4.2 Pfizer Business Overview
12.4.3 Pfizer Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Pfizer Onychomycosis (Tinea Unguium) Drug Products Offered
12.4.5 Pfizer Recent Development
12.5 Valeant Pharma
12.5.1 Valeant Pharma Corporation Information
12.5.2 Valeant Pharma Business Overview
12.5.3 Valeant Pharma Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Valeant Pharma Onychomycosis (Tinea Unguium) Drug Products Offered
12.5.5 Valeant Pharma Recent Development
12.6 Kaken Pharmaceutical
12.6.1 Kaken Pharmaceutical Corporation Information
12.6.2 Kaken Pharmaceutical Business Overview
12.6.3 Kaken Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Kaken Pharmaceutical Onychomycosis (Tinea Unguium) Drug Products Offered
12.6.5 Kaken Pharmaceutical Recent Development
12.7 Galderma
12.7.1 Galderma Corporation Information
12.7.2 Galderma Business Overview
12.7.3 Galderma Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Galderma Onychomycosis (Tinea Unguium) Drug Products Offered
12.7.5 Galderma Recent Development
12.8 Xiuzheng Pharmaceutical
12.8.1 Xiuzheng Pharmaceutical Corporation Information
12.8.2 Xiuzheng Pharmaceutical Business Overview
12.8.3 Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Products Offered
12.8.5 Xiuzheng Pharmaceutical Recent Development
12.9 Letai
12.9.1 Letai Corporation Information
12.9.2 Letai Business Overview
12.9.3 Letai Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Letai Onychomycosis (Tinea Unguium) Drug Products Offered
12.9.5 Letai Recent Development
12.10 Qilu Pharmaceutical
12.10.1 Qilu Pharmaceutical Corporation Information
12.10.2 Qilu Pharmaceutical Business Overview
12.10.3 Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Products Offered
12.10.5 Qilu Pharmaceutical Recent Development
13 Onychomycosis (Tinea Unguium) Drug Manufacturing Cost Analysis
13.1 Onychomycosis (Tinea Unguium) Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Onychomycosis (Tinea Unguium) Drug
13.4 Onychomycosis (Tinea Unguium) Drug Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Onychomycosis (Tinea Unguium) Drug Distributors List
14.3 Onychomycosis (Tinea Unguium) Drug Customers
15 Market Dynamics
15.1 Onychomycosis (Tinea Unguium) Drug Market Trends
15.2 Onychomycosis (Tinea Unguium) Drug Opportunities and Drivers
15.3 Onychomycosis (Tinea Unguium) Drug Market Challenges
15.4 Onychomycosis (Tinea Unguium) Drug Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Onychomycosis (Tinea Unguium) Drug Sales (K Units) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Onychomycosis (Tinea Unguium) Drug Sales (K Units) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Onychomycosis (Tinea Unguium) Drug Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Onychomycosis (Tinea Unguium) Drug Sales (K Units) by Region (2015-2020)
Table 5. Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Region (2015-2020)
Table 6. Global Onychomycosis (Tinea Unguium) Drug Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Onychomycosis (Tinea Unguium) Drug Revenue Share by Region (2015-2020)
Table 8. Global Onychomycosis (Tinea Unguium) Drug Sales (K Units) Forecast by Region (2021-2026)
Table 9. Global Onychomycosis (Tinea Unguium) Drug Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Onychomycosis (Tinea Unguium) Drug Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Onychomycosis (Tinea Unguium) Drug Revenue Share Forecast by Region (2021-2026)
Table 12. Global Onychomycosis (Tinea Unguium) Drug (K Units) of Key Companies (2015-2020)
Table 13. Global Onychomycosis (Tinea Unguium) Drug Sales Share by Company (2015-2020)
Table 14. Global Onychomycosis (Tinea Unguium) Drug Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Onychomycosis (Tinea Unguium) Drug Revenue Share by Company (2015-2020)
Table 16. Global Onychomycosis (Tinea Unguium) Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Onychomycosis (Tinea Unguium) Drug as of 2019)
Table 17. Global Onychomycosis (Tinea Unguium) Drug Average Price (USD/Unit) of Key Company (2015-2020)
Table 18. Manufacturers Onychomycosis (Tinea Unguium) Drug Manufacturing Sites and Area Served
Table 19. Manufacturers Onychomycosis (Tinea Unguium) Drug Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Onychomycosis (Tinea Unguium) Drug Players
Table 22. Global Onychomycosis (Tinea Unguium) Drug Sales (K Units) by Type (2015-2020)
Table 23. Global Onychomycosis (Tinea Unguium) Drug Sales Share by Type (2015-2020)
Table 24. Global Onychomycosis (Tinea Unguium) Drug Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Onychomycosis (Tinea Unguium) Drug Price (K Units) by Type (2015-2020)
Table 26. Global Onychomycosis (Tinea Unguium) Drug Sales Share by Type (2021-2026)
Table 27. Global Onychomycosis (Tinea Unguium) Drug Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Onychomycosis (Tinea Unguium) Drug Revenue Share by Type (2021-2026)
Table 29. Global Onychomycosis (Tinea Unguium) Drug Price (K Units) by Type (2021-2026)
Table 30. Global Onychomycosis (Tinea Unguium) Drug Sales (K Units) by Application (2015-2020)
Table 31. Global Onychomycosis (Tinea Unguium) Drug Sales Share by Application (2015-2020)
Table 32. Global Onychomycosis (Tinea Unguium) Drug Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Onychomycosis (Tinea Unguium) Drug Price (K Units) by Application (2015-2020)
Table 34. Global Onychomycosis (Tinea Unguium) Drug Sales (K Units) by Application (2021-2026)
Table 35. Global Onychomycosis (Tinea Unguium) Drug Sales Share by Application (2021-2026)
Table 36. Global Onychomycosis (Tinea Unguium) Drug Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Onychomycosis (Tinea Unguium) Drug Revenue Share by Application (2021-2026)
Table 38. Global Onychomycosis (Tinea Unguium) Drug Price (K Units) by Application (2021-2026)
Table 39. United States Onychomycosis (Tinea Unguium) Drug Sales (K Units) by Company (2015-2020)
Table 40. United States Onychomycosis (Tinea Unguium) Drug Sales Market Share by Company (2015-2020)
Table 41. United States Onychomycosis (Tinea Unguium) Drug Sales (K Units) by Type (2015-2020)
Table 42. United States Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type (2015-2020)
Table 43. United States Onychomycosis (Tinea Unguium) Drug Sales (K Units) by Application (2015-2020)
Table 44. United States Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application (2015-2020)
Table 45. Europe Onychomycosis (Tinea Unguium) Drug Sales (K Units) by Company (2015-2020)
Table 46. Europe Onychomycosis (Tinea Unguium) Drug Sales Market Share by Company (2015-2020)
Table 47. Europe Onychomycosis (Tinea Unguium) Drug Sales (K Units) by Type (2015-2020)
Table 48. Europe Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type (2015-2020)
Table 49. Europe Onychomycosis (Tinea Unguium) Drug Sales (K Units) by Application (2015-2020)
Table 50. Europe Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type (2015-2020)
Table 51. China Onychomycosis (Tinea Unguium) Drug Sales (K Units) by Company (2015-2020)
Table 52. China Onychomycosis (Tinea Unguium) Drug Sales Market Share by Company (2015-2020)
Table 53. China Onychomycosis (Tinea Unguium) Drug Sales (K Units) by Type (2015-2020)
Table 54. China Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type (2015-2020)
Table 55. China Onychomycosis (Tinea Unguium) Drug Sales (K Units) by Application (2015-2020)
Table 56. China Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application (2015-2020)
Table 57. Japan Onychomycosis (Tinea Unguium) Drug Sales (K Units) by Company (2015-2020)
Table 58. Japan Onychomycosis (Tinea Unguium) Drug Sales Market Share by Company (2015-2020)
Table 59. Japan Onychomycosis (Tinea Unguium) Drug Sales (K Units) by Type (2015-2020)
Table 60. Japan Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type (2015-2020)
Table 61. Japan Onychomycosis (Tinea Unguium) Drug Sales (K Units) by Application (2015-2020)
Table 62. Japan Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Onychomycosis (Tinea Unguium) Drug Sales (K Units) by Company (2015-2020)
Table 64. Southeast Asia Onychomycosis (Tinea Unguium) Drug Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Onychomycosis (Tinea Unguium) Drug Sales (K Units) by Type (2015-2020)
Table 66. Southeast Asia Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Onychomycosis (Tinea Unguium) Drug Sales (K Units) by Type (2015-2020)
Table 68. Southeast Asia Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application (2015-2020)
Table 69. India Onychomycosis (Tinea Unguium) Drug Sales (K Units) by Company (2015-2020)
Table 70. India Onychomycosis (Tinea Unguium) Drug Sales Market Share by Company (2015-2020)
Table 71. India Onychomycosis (Tinea Unguium) Drug Sales (K Units) by Type (2015-2020)
Table 72. India Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type (2015-2020)
Table 73. India Onychomycosis (Tinea Unguium) Drug Sales (K Units) by Application (2015-2020)
Table 74. India Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application (2015-2020)
Table 75. Johnson and Johnson Corporation Information
Table 76. Johnson and Johnson Description and Business Overview
Table 77. Johnson and Johnson Onychomycosis (Tinea Unguium) Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Johnson and Johnson Onychomycosis (Tinea Unguium) Drug Product
Table 79. Johnson and Johnson Recent Development
Table 80. GSK Corporation Information
Table 81. GSK Description and Business Overview
Table 82. GSK Onychomycosis (Tinea Unguium) Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. GSK Onychomycosis (Tinea Unguium) Drug Product
Table 84. GSK Recent Development
Table 85. Novartis Corporation Information
Table 86. Novartis Description and Business Overview
Table 87. Novartis Onychomycosis (Tinea Unguium) Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Novartis Onychomycosis (Tinea Unguium) Drug Product
Table 89. Novartis Recent Development
Table 90. Pfizer Corporation Information
Table 91. Pfizer Description and Business Overview
Table 92. Pfizer Onychomycosis (Tinea Unguium) Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Pfizer Onychomycosis (Tinea Unguium) Drug Product
Table 94. Pfizer Recent Development
Table 95. Valeant Pharma Corporation Information
Table 96. Valeant Pharma Description and Business Overview
Table 97. Valeant Pharma Onychomycosis (Tinea Unguium) Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Valeant Pharma Onychomycosis (Tinea Unguium) Drug Product
Table 99. Valeant Pharma Recent Development
Table 100. Kaken Pharmaceutical Corporation Information
Table 101. Kaken Pharmaceutical Description and Business Overview
Table 102. Kaken Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Kaken Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product
Table 104. Kaken Pharmaceutical Recent Development
Table 105. Galderma Corporation Information
Table 106. Galderma Description and Business Overview
Table 107. Galderma Onychomycosis (Tinea Unguium) Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Galderma Onychomycosis (Tinea Unguium) Drug Product
Table 109. Galderma Recent Development
Table 110. Xiuzheng Pharmaceutical Corporation Information
Table 111. Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Xiuzheng Pharmaceutical Description and Business Overview
Table 113. Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product
Table 114. Xiuzheng Pharmaceutical Recent Development
Table 115. Letai Corporation Information
Table 116. Letai Onychomycosis (Tinea Unguium) Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Letai Description and Business Overview
Table 118. Letai Onychomycosis (Tinea Unguium) Drug Product
Table 119. Letai Recent Development
Table 120. Qilu Pharmaceutical Corporation Information
Table 121. Qilu Pharmaceutical Description and Business Overview
Table 122. Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 123. Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product
Table 124. Qilu Pharmaceutical Recent Development
Table 125. Production Base and Market Concentration Rate of Raw Material
Table 126. Key Suppliers of Raw Materials
Table 127. Onychomycosis (Tinea Unguium) Drug Distributors List
Table 128. Onychomycosis (Tinea Unguium) Drug Customers List
Table 129. Onychomycosis (Tinea Unguium) Drug Market Key Trends
Table 130. Onychomycosis (Tinea Unguium) Drug Key Opportunities and Drivers
Table 131. Onychomycosis (Tinea Unguium) Drug Market Challenges
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Onychomycosis (Tinea Unguium) Drug Product Picture
Figure 2. Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Onychomycosis (Tinea Unguium) Drug Market Share by Application in 2020 & 2026
Figure 6. Age under 18 Examples
Figure 7. Age 18-50 Examples
Figure 8. Age above 50 Examples
Figure 9. Global Onychomycosis (Tinea Unguium) Drug Sales (K Units) Growth Rate (2015-2026)
Figure 10. Global Onychomycosis (Tinea Unguium) Drug Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Onychomycosis (Tinea Unguium) Drug Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 12. Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Onychomycosis (Tinea Unguium) Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Onychomycosis (Tinea Unguium) Drug Sales (K Units) Growth Rate (2015-2026)
Figure 16. Europe Onychomycosis (Tinea Unguium) Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Onychomycosis (Tinea Unguium) Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Onychomycosis (Tinea Unguium) Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Onychomycosis (Tinea Unguium) Drug Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Onychomycosis (Tinea Unguium) Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Onychomycosis (Tinea Unguium) Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Onychomycosis (Tinea Unguium) Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Onychomycosis (Tinea Unguium) Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Onychomycosis (Tinea Unguium) Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Onychomycosis (Tinea Unguium) Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Onychomycosis (Tinea Unguium) Drug Players Market Share by Revenue in Onychomycosis (Tinea Unguium) Drug 2015 & 2019
Figure 27. Onychomycosis (Tinea Unguium) Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Onychomycosis (Tinea Unguium) Drug Revenue Share by Type (2015-2020)
Figure 29. Global Onychomycosis (Tinea Unguium) Drug Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Onychomycosis (Tinea Unguium) Drug Revenue Share by Application (2015-2020)
Figure 31. Global Onychomycosis (Tinea Unguium) Drug Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type in 2019
Figure 33. United States Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type in 2019
Figure 34. Europe Onychomycosis (Tinea Unguium) Drug Sales Market Share by Company in 2019
Figure 35. Europe Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type in 2019
Figure 36. Europe Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application in 2019
Figure 37. China Onychomycosis (Tinea Unguium) Drug Sales Market Share by Company in 2019
Figure 38. China Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type in 2019
Figure 39. China Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application in 2019
Figure 40. Japan Onychomycosis (Tinea Unguium) Drug Sales Market Share by Company in 2019
Figure 41. Japan Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type in 2019
Figure 42. Japan Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application in 2019
Figure 43. Southeast Asia Onychomycosis (Tinea Unguium) Drug Sales Market Share by Company in 2019
Figure 44. Southeast Asia Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type in 2019
Figure 45. Southeast Asia Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application in 2019
Figure 46. India Onychomycosis (Tinea Unguium) Drug Sales Market Share by Company in 2019
Figure 47. India Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type in 2019
Figure 48. India Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application in 2019
Figure 49. Key Raw Materials Price Trend
Figure 50. Manufacturing Cost Structure of Onychomycosis (Tinea Unguium) Drug
Figure 51. Manufacturing Process Analysis of Onychomycosis (Tinea Unguium) Drug
Figure 52. Onychomycosis (Tinea Unguium) Drug Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Porter's Five Forces Analysis
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
ドラッグキャビネットの世界市場レポート2020 Market Analysis and Insights: Global Drug Cabinets Market The global Drug Cabinets market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Drug Cabinets Scope and Market Size The global Drug Cabinets market is segmented by comp…- 口腔液薬物検査システムの世界市場レポート2020 Oral fluid testing analyzes a saliva sample for parent drugs and their metabolites. An absorbent collection device is placed in the mouth and the saliva collected is screened for drugs of abuse. Samples are checked to verify the saliva is human and undiluted. The industry's leading manufacturers are…
- 経口制御ドラッグデリバリーシステムの世界市場レポート2020 Market Analysis and Insights: Global Oral Controlled Drug Delivery System Market The global Oral Controlled Drug Delivery System market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Oral Controlled Drug Delivery System Scope…
- 消化器系治療薬の世界市場レポート2020 Market Analysis and Insights: Global Digestive System Drug Market The global Digestive System Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Digestive System Drug Scope and Market Size The global Digestive System …
- 甲状腺ホルモン薬の世界市場レポート2020 Market Analysis and Insights: Global Thyroid Hormone Disorder Drug Market The global Thyroid Hormone Disorder Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Thyroid Hormone Disorder Drug Scope and Market Size The …